Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Post-recurrence survival in patients with cervical cancer

David Cibula,Lukáš Dostálek,Jiri Jarkovsky,Constantijne H Mom,Aldo Lopez,Henrik Falconer,Giovanni Scambia,Ali Ayhan,Sarah H Kim,David Isla Ortiz,Jaroslav Klat,Andreas Obermair,Giampaolo Di Martino,Rene Pareja,Ranjit Manchanda,Jan Kosťun,Ricardo Dos Reis,Mehmet Mutlu Meydanli,Diego Odetto,Rene Laky,Ignacio Zapardiel,Vit Weinberger,Klára Benešová,Martina Borčinová, Fernando Cardenas,Emelie Wallin,Luigi Pedone Anchora,Huseyin Akilli,Nadeem R Abu-Rustum,Salim Abraham Barquet-Muñoz,Veronika Javůrková,Daniela Fischerová,Luc R C W van Lonkhuijzen

Gynecologic Oncology（2022）

Cited 10|Views24
No score
Abstract
•The 5-year post-recurrence disease-specific survival (PR-DSS) rate was 39.1% in patients with early-stage cervical cancer.•The strongest factors for PR-DSS were primary tumour size and the presence of symptoms at diagnosis of recurrence.•The presence of symptoms at recurrence remained a significant prognostic factor after correction for lead-time bias.•PR-DSS was best in patients without LN involvement or LVSI suffering from solitary asymptomatic recurrence.
More
Translated text
Key words
Early-stage cervical cancer,Recurrence,Post-recurrence disease-specific survival,Prognosis,Multivariable model,Risk profile
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined